Income statement
CAD
Annual
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2K | 12K | 74K | 0 | 0 |
| Gross Profit | -2K | -43K | 5K | 0 | 0 |
| Operating Income | -4M | -5M | -6M | -32K | -2K |
| EBITDA | -4M | -4M | -8M | -2K | -2K |
| Net Income | -4M | -4M | -9M | -17K | -5K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 8, 2026
Coverage: 241 bars · Jun 23, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tevano Systems Holdings Inc. (TEVNF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of -81.6%, EPS growth of +33.3%, a dividend yield of 0.0%. What stands out right now is revenue -81.6%, EPS +33.3%, free cash flow +73.6% with operating margin -188147.7% and ROIC 316.3%. Valuation already assumes a fairly strong business story at price/sales 637.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TEVNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TEVNF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TEVNF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TEVNF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$5.0K
+71.0% YoY
Free Cash Flow
-$69.3K
-1129.4% YoY
Revenue Growth
-81.6%
EPS Growth
+33.3%
Gross Margin
-92.0%
Net Margin
-166572.2%
Income statement
CAD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2K | 12K | 74K | 0 | 0 |
| Gross Profit | -2K | -43K | 5K | 0 | 0 |
| Operating Income | -4M | -5M | -6M | -32K | -2K |
| EBITDA | -4M | -4M | -8M | -2K | -2K |
| Net Income | -4M | -4M | -9M | -17K | -5K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 34K | 6K | 678K | 2M | 13K |
| Total Assets | 47K | 75K | 2M | 26K | 28K |
| Total Liabilities | 1M | 1M | 2M | 126K | 111K |
| Shareholder Equity | -1M | -938K | -737K | -100K | -83K |
| Total Debt | 15K | 130K | 1M | 1M | 0 |
| Net Debt | -19K | 124K | 499K | -1M | -13K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
69K
-920.8% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
69K
-1129.4% YoY
Key ratios
Gross Margin
-92.0%
Operating Margin
-188147.7%
Net Margin
-166572.2%
ROE
322.4%
Debt / Equity
-0.01x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.